For example, mutations in PTPN11, a driver gene in MDS/AML, result in exacerbation of intestinal inflammation by disrupting BM-derived macrophage responsiveness to IL-10 (ref. 58). This evidence concerns the gene PTPN11 and myelodysplastic syndrome.